Anil Singh, MD
Cardiology · Cumberland, MDNPI 1770587313
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $427 and has fallen 57.4% since, to $182 in 2025.
Across 102 payments — averaging $19.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$459
- Merck$200
- Actelion Pharmaceuticals US, Inc.$175
- Johnson & Johnson$171
- Boehringer Ingelheim$170
- Pfizer$160
- plus $692 from 15 others
What the payments were for
- Food & beverage$1,92495%
- Education$1025%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $459 |
| Merck | 13 | $200 |
| Actelion Pharmaceuticals US, Inc. | 8 | $175 |
| Johnson & Johnson | 9 | $171 |
| Boehringer Ingelheim | 10 | $170 |
| Pfizer | 9 | $160 |
| E.r. Squibb & Sons, L.L.C. | 7 | $128 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $81 |
| Medtronic | 1 | $70 |
| Boston Scientific | 3 | $58 |
| Novartis | 3 | $53 |
| Inspire Medical Systems, Inc. | 1 | $46 |
| Esperion Therapeutics, Inc. | 2 | $43 |
| Silk Road Medical, Inc. | 1 | $43 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $40 |
| Abbott | 2 | $33 |
| Chiesi USA, Inc. | 1 | $26 |
| Philips North America LLC | 1 | $21 |
| Irhythm Technologies, Inc. | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Scpharmaceuticals Inc. | 1 | $16 |
How this compares
$2,026 in reported general payments places this provider in the 80th percentile of 44 cardiology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 97 | $86,591 |
| EliquisApixaban | 98 | $77,673 |
| EntrestoSacubitril/Valsartan | 16 | $13,355 |
| Metoprolol Succinate | 146 | $2,430 |
| Ezetimibe | 37 | $1,513 |
| Atorvastatin Calcium | 128 | $1,129 |
| Terazosin Hcl | 26 | $1,016 |
| Flecainide Acetate | 17 | $1,001 |
| Lisinopril | 118 | $972 |
| Amlodipine Besylate | 154 | $926 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 103 | $852 |
| Metoprolol Tartrate | 167 | $828 |
| Losartan Potassium | 88 | $808 |
| Ramipril | 31 | $646 |
| Potassium Chloride | 34 | $595 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $171 | $86,59197 claims |
| PfizerEliquis | $160 | $77,67398 claims |
| NovartisEntresto | $53 | $13,35516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 44 cardiology providers in Maryland.
Other cardiology in Cumberland
- Pradeep KulkarniCumberland$709
- Baljeet MahalCumberland$181
- Mohammadali HabibiBaltimore$15K
- Ayim Akyea DjamsonBeltsville$11K
- Michael WilberBaltimore$5K
- Eva HausnerovaChevy Chase$4K
- Hassanali KassamaliBaltimore$4K
- John ConditEaston$3K
- Pankaj LalRockville$3K
- Timothy ShanahanEaston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.